This ad is getting a lot of attention from my readers, if my inbox is any indication — it’s for the Phase 1 Investor service from Stansberry & Associates, which is their expensive premium letter that has historically focused mostly on biotech stocks but is also used by them for any super-tiny stocks that would [...]
by dmanson on March 21, 2010 at 10:45 pm
by ehsu on March 21, 2010 at 9:56 pm
by Dirk Carson on March 21, 2010 at 8:37 am
by Steve on March 20, 2010 at 11:52 pm
by Pemonte on March 20, 2010 at 8:47 pm